Get the Stockscreener App
4.74
0.63%
-0.03
Sanuwave Health Inc stock is traded at $4.74, with a volume of 109.44K.
It is down -0.63% in the last 24 hours and down -60.37% over the past month.
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
See More
Previous Close:
$4.77
Open:
$4.81
24h Volume:
109.44K
Relative Volume:
0.54
Market Cap:
$40.77M
Revenue:
$44.33M
Net Income/Loss:
$16.05M
P/E Ratio:
14.50
EPS:
0.3269
Net Cash Flow:
$3.85M
1W Performance:
-19.39%
1M Performance:
-60.37%
6M Performance:
-80.96%
1Y Performance:
-87.45%
1-Day Range:
$4.655
$5.0486
1-Week Range:
$4.655
$5.965
52-Week Range:
$4.655
$45.33
Sanuwave Health Inc Stock (SNWV) Company Profile
Name
Sanuwave Health Inc
Sector
Industry
Phone
952-656-1029
Address
9600 W. 6TH SSTREET, EDEN PRAIRIE
Compare SNWV vs MOBBW, PSNYW, GOODO, SHMD, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNWV
Sanuwave Health Inc
|
29.00 | 34.02M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
1.86 | 2.83B | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.89 | 388.34M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.88 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
5.45 | 348.74M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
48.03 | 0 | 0 | 0 | 0 | 0.00 |
Sanuwave Health Inc Stock (SNWV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Initiated | Northland Capital | Outperform |
| Jul-29-25 | Initiated | Roth Capital | Buy |
Sanuwave Health Inc Stock (SNWV) Latest News
Solas Capital discloses 7.1% SANUWAVE Health (SNWV) position via managed funds - Stock Titan
Sanuwave Q2 2026 slides: consumables rise as system sales slide - Investing.com
SANUWAVE Health Inc (SNWV) (Q2 2026) Earnings Call Highlights: R - GuruFocus
SNWV Looks 52.0% Undervalued on GF Value™ - GuruFocus
SANUWAVE Health Inc (SNWV) (Q2 2026) Earnings Call Highlights: Record Applicator Sales Offset ... - Yahoo Finance
Earnings call transcript: Sanuwave Health misses Q2 2026 estimates as sales slide - Investing.com
Sanuwave Health Q2 Earnings Call Highlights - Yahoo Finance
SANUWAVE Health, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:SNWV) 2026-08-07 - Seeking Alpha
Q2 2026 SANUWAVE Health Inc Earnings Call Transcript - GuruFocus
Form 8K SANUWAVE Health Inc For: 6 August By Investing.com - Investing.com Nigeria
Sanuwave Q2 2026 slides: consumables rise as system sales slide By Investing.com - Investing.com Canada
Sanuwave Health (SNWV) to Release Quarterly Earnings on Friday - MarketBeat
SANUWAVE ANNOUNCES Q2 FY2026 FINANCIAL RESULTS - Moomoo
SNWV: Revenue and profitability declined in Q2 2026, with lower system sales and higher expenses - TradingView
Is SANUWAVE Health Inc (SNWV) a Value Opportunity After Q2 Earni - GuruFocus
Sanuwave Health Q2 2026 Earnings Call Transcript - MarketBeat
SANUWAVE Q2 net loss turns to USD 682,000; revenue falls 3% to USD 9.74 million vs Q2 FY25 - Bitget
SNWV: Q2 2026 saw lower revenue and margins, with guidance withdrawn amid Medicare uncertainty - TradingView
SANUWAVE Health, Inc. Q2 2026: Revenue $9.74M, EPS $(0.08) — 10-Q Summary - TradingView
Sanuwave Announces Q2 FY2026 Financial Results - The Manila Times
SANUWAVE Health Q2 revenue falls, withdraws FY guidance amid Medicare reimbursement uncertainty - TradingView
SANUWAVE Health reports Q2 FY2026 revenue $9.7M, GAAP operating loss $(0.3)M and Adjusted EBITDA $1.2M - TradingView
Sanuwave Health Reports Q2 2026 Financial Results, Withdraws Full-Year Guidance on Medicare Reimbursement Uncertainty - Quiver Quantitative
Sanuwave Q2 Revenue Falls 3 Percent to $9.7 Million - Quiver Quantitative
SANUWAVE Health 2Q Loss/Shr 8c >SNWV - Moomoo
Earnings To Watch: SANUWAVE Health Inc (SNWV) Q2 2026 -- GF Value Sees 166% Upside - Yahoo Finance
SNWV Q2 FY2026 earnings call - finance.biggo.com
BlackRock, Inc. Reduces SANUWAVE Health Inc (SNWV) Stake -- Shar - GuruFocus
SANUWAVE Health (SNWV.US) will release its earnings report before market open on August 7. - Moomoo
Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results - The Manila Times
Sanuwave Health to Host Q2 2026 Financial Results Conference Call on August 7 - Quiver Quantitative
Sanuwave Health Q2 Results: Earnings call scheduled for August 7 - scanx.trade
SANUWAVE Health, Inc. Revenue Breakdown – NASDAQ:SNWV - TradingView
SNWV|SNWV|Price:6.170|Chg%:+0.240 - TradingKey
SNWV Q1 2026 Earnings: Significant EPS Miss Amid Operational ChallengesInvestor Earnings Call - dars.gov.et
SNWV Q1 2026 Earnings: EPS Misses Estimates Sharply as Losses Widen; Stock Falls 5.2%Diluted EPS Report - dars.gov.et
Calendrier des PAPE pour: - Yahoo Finance France
What's going on with SANUWAVE Health stock on Friday? - MSN
Sanuwave Q2 revenue exceeds revised guidance on record consumable sales - scanx.trade
What's Going On With SANUWAVE Health Stock On Friday? - Benzinga
SANUWAVE Health (SNWV) Stock Forum and Discussion - Moomoo
Sanuwave sees Q2 revenue up to $9.8M - MSN
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance - Ortho Spine News
Sanuwave Health preliminary revenue increases up to 5% in Q2 2026 - Medical Buyer
Sanuwave Health (SNWV) Raises Q2 Revenue Expectations to $9.6M-$9.8M - GuruFocus
Sanuwave Health Reports Q2 2026 Revenue Above Guidance Amid Record Consumable Sales and Used System Market Growth - Minichart
Sanuwave Health (SNWV) Reports Second Quarter Revenue Expectatio - GuruFocus
Sanuwave Health, Inc. Revises Earnings Guidance for the Second Quarter Ended June 30, 2026 - marketscreener.com
Sanuwave posts Q2 revenue of $9.6M-$9.8M, beating guidance By Investing.com - Investing.com Nigeria
Sanuwave posts Q2 revenue of $9.6M-$9.8M, beating guidance - Investing.com
Sanuwave Health Inc Stock (SNWV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):